Bone Marrow Failure Disease Scientific Symposium 2022
Listen to Neal Young, MD, and Richard Stone, MD, describe the value of attending the Eighth International Bone Marrow Failure Scientific Symposium on May 19-20, 2022.
This biennial Scientific Symposium is the only international forum focused solely on bone marrow failure diseases. Join the world’s leading researchers on aplastic anemia, MDS, and PNH to discuss current areas of consensus and controversy, share recent research results, and identify the highest-priority directions for basic and clinical research to advance the field.
The specific aims of this Symposium are to:
• Foster collaborations among basic, clinical, and translational scientists and between scientists studying different diseases to help researchers better understand the diseases, form networks to advance their own research, and identify new approaches to transform findings into treatments
• Increase participants’ understanding of the molecular events that drive these diseases and the responses to treatment required to define at-risk populations and improve current therapies
• Develop recommendations for advancing basic, clinical, and translational research in bone marrow failure diseases
• Provide important opportunities to train and encourage young investigators to pursue a career in bone marrow failure disease research
Symposium Co-Chairs: Richard Stone, MD, Dana-Farber Cancer Institute and Neal Young, MD, NHLBI
Symposium sessions include:
Thursday, May 19
• Genetics and Genomics of Bone Marrow Failure
• Somatic Mutations in Benign Diseases: AA, PNH, VEXAS Syndrome
• Advances in Paroxysmal Nocturnal Hemoglobinuria
• Transplantation for Bone Marrow Failure
• Non-transplant Therapies for Marrow Failure
Friday, May 20
• MDS and Secondary AML Pathophysiology
• MDS Tools for Prognosis: Regaining Consensus
• Treatments for MDS and Secondary AML
Abstracts summarizing new, ongoing, or updated research in bone marrow failure may be submitted by April 30, 2022 to be considered for the Poster Session. Learn more here
Travel Support for New Investigators
Travel support is available for new investigators to attend the symposium – learn more here
The symposium is supported by educational grants from Novartis, Alexion, Apellis, Biocryst, Regeneron, and Geron.
Great Debates & Updates in Hematologic Malignancies
Great Debates & Updates in Hematologic Malignancies is a unique series that combines didactic presentations and lively and interactive debates. This year, the four virtual dates and one in-person conference in New York City will cover provocative scientific topics impacting the field, such as multiple myeloma, acute and chronic lymphocytic and myeloid leukemia, lymphoma, and so much more. View the agendas and reserve your complimentary seat today: hemeoncologydebates.com!